Research - Revance Therapeutics (RVNC) reported topline data from their long-running cervical dystonia study with RT002 last night. Most importantly, all three cohorts (<200units, 200-300 units, and … Continue Reading
You're all done! We've sent you a confirmation email that includes a verification link. To access the page you're interested in, check your email inbox(including spam folder) and click the verification link.